Prosecution Insights
Last updated: April 19, 2026

Ocugen Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
0
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18503177 Treatment of Neurological Disorder Using NHR PURDY, KYLE A 1611 Non-Final OA Nov 06, 2023
18197692 METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTS SCHERBEL, TODD J 3771 Non-Final OA May 15, 2023
17668511 NEOCARTILAGE CONSTRUCTS USING UNIVERSAL CELLS BOECKELMAN, JACOB A 1655 Non-Final OA Feb 10, 2022
16973987 SCAFFOLD WITH ADHESIVE FOR ARTICULAR CARTILAGE REPAIR HOBAN, MELISSA A 3774 Non-Final OA Dec 10, 2020
17080078 ADENO-ASSOCIATED VIRUS VECTOR MEDIATED GENE THERAPY FOR OPHTHALMIC DISEASES REGLAS, GEORGIANA C 1651 Non-Final OA Oct 26, 2020

Managing Ocugen Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month